Palatin Technologies

+$0.005 (+1.84%) As of 2:30 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTN and other ETFs, options, and stocks.

About PTN

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).

CEO
Carl Spana
Employees
—
Headquarters
Cranbury, New Jersey
Founded
1986

PTN Key Statistics

Market cap
64.77M
Price-Earnings ratio
—
Dividend yield
—
Average volume
712.84K
High today
$0.2863
Low today
$0.2686
Open price
$0.2686
Volume
145.16K
52 Week high
$0.96
52 Week low
$0.258

PTN Earnings

-$0.06
-$0.04
-$0.02
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Actual
Expected Sep 27, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure